Drug
Avexitide
Avexitide: highest development phase Phase 3, developed by Amylyx Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Amylyx Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Avexitide NCT06747468 | Phase 3 | Post Bariatric Hypoglycemia |
Latest
No recent events.
Follow Avexitide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.